Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury?
Sartori
S
S
St. Anna General Hospital, Ferrara, Italy.
Nielsen
I
I
Indelli
M
M
Trevisani
L
L
Pazzi
P
P
Grandi
E
E
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000139:chemically induced* / Q000175:diagnosis; D001706:Biopsy; D001943:Breast Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004945:Esophagoscopy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011446:Prospective Studies
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate